Group 1 - The company is holding its second extraordinary general meeting of shareholders in 2025 to ensure the rights of all shareholders and maintain order during the meeting [1][2] - Only shareholders, their proxies, company directors, supervisors, senior management, and invited personnel are allowed to attend the meeting, while other unrelated individuals may be refused entry [1][2] - Shareholders and their proxies must arrive 20 minutes before the meeting to sign in and present necessary identification documents [1][2] Group 2 - The meeting will announce the number of shareholders present and the total voting rights held before allowing any latecomers to participate in voting [2] - Shareholders have the right to speak, inquire, and vote during the meeting, but must adhere to the agenda and time limits for speaking [2][3] - The meeting will utilize both on-site and online voting methods, with specific time slots designated for each [4][5] Group 3 - The agenda includes the establishment of a private equity fund and related party transactions, with a proposed fundraising scale of RMB 1.5 billion [5][6] - The fund will focus on investments in the semiconductor and strategic emerging sectors, with the company planning to contribute up to RMB 735 million [5][6] - The proposal has been approved by the company's board and is now subject to shareholder voting [6]

Group 1 - The company Shenzhen Ruijie Technology Co., Ltd. announced a joint investment with professional investment institutions through its wholly-owned subsidiary Shenzhen Ruijie Investment Co., Ltd. to deepen its industrial layout and promote the development of its main business [1][2] - The total subscription scale of the investment in the Guangzhou Guangjian Science and Technology Venture Capital Fund is RMB 40.76 million, with Shenzhen Ruijie contributing RMB 10 million, accounting for 24.53% of the total [1] - The name of the partnership fund has been changed from Guangzhou Guangjian Science and Technology Venture Capital Fund to Guangzhou Aiyisai Venture Capital Fund, while other terms remain unchanged [2] Group 2 - The fund has completed the filing procedures with the Asset Management Association of China in accordance with relevant laws and regulations, and has obtained the Private Investment Fund Filing Certificate [2]

Group 1 - The company held a board meeting on June 3, 2025, where all procedures complied with relevant laws and regulations [1] - The board approved a proposal to establish a private investment fund with a target fundraising size of RMB 1.5 billion, focusing on semiconductor and strategic emerging sectors [2] - The company plans to contribute up to RMB 735 million, representing no more than 49% of the fund's total size [2] Group 2 - The board approved adjustments to the 2025 restricted stock incentive plan due to 12 individuals no longer qualifying as incentive recipients, reducing the number of recipients from 2,470 to 2,458 [3] - The total number of restricted stocks to be granted remains unchanged, with adjustments made based on factors such as tenure and performance [3] - The board agreed to grant 10 million restricted stocks at a price of RMB 100 per share to the adjusted list of recipients on June 10, 2025 [4] Group 3 - A proposal was made to convene the second extraordinary general meeting of shareholders on June 26, 2025, which received unanimous approval from the board [4]

Investment Overview - The company has signed a partnership agreement with Jiang Sai Zhi Bo Le Equity Investment Management Co., Ltd., Zhejiang University Net New Technology Co., Ltd., and Hangzhou Jingye Intelligent Technology Co., Ltd. to jointly invest in Hangzhou Sai Zhi Zhu Long Venture Capital Partnership (Limited Partnership) [1] - The target total fundraising scale of the investment fund is RMB 100 million, with the company contributing RMB 33 million, accounting for 33% of the total fundraising scale [1] Fund Progress - The investment fund has completed the business registration process and obtained a business license from the market supervision and management department [2] - The fund has also completed the private investment fund registration procedures with the Asset Management Association of China, obtaining the Private Investment Fund Registration Certificate [2]

第一医药（600833）公告，公司参与投资设立的上海创特私募投资基金合伙企业(有限合伙)已完成工商 注册登记。基金规模5600万元，首期实缴出资1000万元。截至公告日，基金首期实缴已完成，基金各合 伙人实缴出资情况如下：上海商投创业投资有限公司(GP、管理人)100万元，上海百联国泰君安创领私 募基金合伙企业(有限合伙)(LP)600万元，上海第一医药股份有限公司(LP)100万元，上海奉贤生物科技 园区开发有限公司(LP)100万元，淮安科创产业投资有限公司(LP)100万元，合计1000万元。 ...